AAAAAA

   
Results: 1-13 |
Results: 13
PHASE-II STUDY OF DOSE-DENSE HIGH-DOSE CHEMOTHERAPY TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS PRIMARY-TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CANCER
Authors: AGHAJANIAN C FENNELLY D SHAPIRO F WALTZMAN R ALMADRONES L OFLAHERTY C OCONNER K VENKATRAMAN E BARAKAT R CURTIN J BROWN C REICH L WUEST D NORTON L HOSKINS W SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-II STUDY OF DOSE-DENSE HIGH-DOSE CHEMOTHERAPY TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS PRIMARY-TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1852-1860
A PHASE-II TRIAL OF INTRAPERITONEAL CISPLATIN AND ETOPOSIDE AS CONSOLIDATION THERAPY IN PATIENTS WITH STAGE II-IV EPITHELIAL OVARIAN-CANCERFOLLOWING NEGATIVE SURGICAL ASSESSMENT
Authors: BARAKAT RR ALMADRONES L VENKATRAMAN ES AGHAJANIAN C BROWN C SHAPIRO F CURTIN JP SPRIGGS D
Citation: Rr. Barakat et al., A PHASE-II TRIAL OF INTRAPERITONEAL CISPLATIN AND ETOPOSIDE AS CONSOLIDATION THERAPY IN PATIENTS WITH STAGE II-IV EPITHELIAL OVARIAN-CANCERFOLLOWING NEGATIVE SURGICAL ASSESSMENT, Gynecologic oncology, 69(1), 1998, pp. 17-22
PALLIATIVE BENEFIT OF EXTERNAL-BEAM RADIATION IN THE MANAGEMENT OF PLATINUM REFRACTORY EPITHELIAL OVARIAN-CARCINOMA
Authors: GELBLUM D MYCHALCZAK B ALMADRONES L SPRIGGS D BARAKAT R
Citation: D. Gelblum et al., PALLIATIVE BENEFIT OF EXTERNAL-BEAM RADIATION IN THE MANAGEMENT OF PLATINUM REFRACTORY EPITHELIAL OVARIAN-CARCINOMA, Gynecologic oncology, 69(1), 1998, pp. 36-41
HIGH-INTENSITY INTRAVENOUS CYCLOPHOSPHAMIDE AND CISPLATIN, INTERIM SURGICAL DEBULKING, AND INTRAPERITONEAL CISPLATIN IN ADVANCED OVARIAN-CARCINOMA - A PILOT TRIAL WITH 10-YEAR FOLLOW-UP
Authors: SHAPIRO F SCHNEIDER J MARKMAN M REICHMAN BS VENKATRAMAN E BARAKAT R ALMADRONES L SPRIGGS D
Citation: F. Shapiro et al., HIGH-INTENSITY INTRAVENOUS CYCLOPHOSPHAMIDE AND CISPLATIN, INTERIM SURGICAL DEBULKING, AND INTRAPERITONEAL CISPLATIN IN ADVANCED OVARIAN-CARCINOMA - A PILOT TRIAL WITH 10-YEAR FOLLOW-UP, Gynecologic oncology, 67(1), 1997, pp. 39-45
FOLLOW-UP OF MEMORIAL-SLOAN-KETTERING-CANCER-CENTER PATIENTS TREATED ON NATIONAL-CANCER-INSTITUTE TREATMENT REFERRAL CENTER PROTOCOL-9103 -PACLITAXEL IN REFRACTORY OVARIAN-CANCER
Authors: MARKMAN M HAKES T BARAKAT R CURTIN J ALMADRONES L HOSKINS W
Citation: M. Markman et al., FOLLOW-UP OF MEMORIAL-SLOAN-KETTERING-CANCER-CENTER PATIENTS TREATED ON NATIONAL-CANCER-INSTITUTE TREATMENT REFERRAL CENTER PROTOCOL-9103 -PACLITAXEL IN REFRACTORY OVARIAN-CANCER, Journal of clinical oncology, 14(3), 1996, pp. 796-799
ADJUVANT CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS PELVIC IRRADIATION FORHIGH-RISK CERVICAL-CANCER PATIENTS AFTER RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY (RH-PLND) - A RANDOMIZED PHASE-III TRIAL
Authors: CURTIN JP HOSKINS WJ VENKATRAMAN ES ALMADRONES L PODRATZ KC LONG H TENERIELLO M AVERETTE H SEVIN BU
Citation: Jp. Curtin et al., ADJUVANT CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS PELVIC IRRADIATION FORHIGH-RISK CERVICAL-CANCER PATIENTS AFTER RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY (RH-PLND) - A RANDOMIZED PHASE-III TRIAL, Gynecologic oncology, 61(1), 1996, pp. 3-10
THE IMPACT OF DIABETES-MELLITUS ON THE TOXICITY OF THERAPY FOR ADVANCED OVARIAN-CANCER
Authors: GOGAS H SHAPIRO F AGHAJANIAN C FENNELLY D ALMADRONES L HOSKINS WJ SPRIGGS DR
Citation: H. Gogas et al., THE IMPACT OF DIABETES-MELLITUS ON THE TOXICITY OF THERAPY FOR ADVANCED OVARIAN-CANCER, Gynecologic oncology, 61(1), 1996, pp. 22-26
MITOMYCIN-C PLUS A 3-DAY CONTINUOUS INTRAVENOUS-INFUSION OF 5-FLUOROURACIL - AN INACTIVE SALVAGE REGIMEN FOR PLATINUM-RESISTANT OVARIAN-CARCINOMA
Authors: REICHMAN B MARKMAN M HAKES T RUBIN S JONES W CURTIN J BARAKAT R ALMADRONES L LEWIS JL HOSKINS W
Citation: B. Reichman et al., MITOMYCIN-C PLUS A 3-DAY CONTINUOUS INTRAVENOUS-INFUSION OF 5-FLUOROURACIL - AN INACTIVE SALVAGE REGIMEN FOR PLATINUM-RESISTANT OVARIAN-CARCINOMA, Gynecologic oncology, 50(1), 1993, pp. 30-33
EVIDENCE SUPPORTING THE SUPERIORITY OF INTRAPERITONEAL CISPLATIN COMPARED TO INTRAPERITONEAL CARBOPLATIN FOR SALVAGE THERAPY OF SMALL-VOLUME RESIDUAL OVARIAN-CANCER
Authors: MARKMAN M REICHMAN B HAKES T RUBIN S LEWIS JL JONES W BARAKAT R CURTIN J ALMADRONES L HOSKINS W
Citation: M. Markman et al., EVIDENCE SUPPORTING THE SUPERIORITY OF INTRAPERITONEAL CISPLATIN COMPARED TO INTRAPERITONEAL CARBOPLATIN FOR SALVAGE THERAPY OF SMALL-VOLUME RESIDUAL OVARIAN-CANCER, Gynecologic oncology, 50(1), 1993, pp. 100-104
THE USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO PREVENT CARBOPLATIN-INDUCED ANEMIA
Authors: MARKMAN M REICHMAN B HAKES T RUBIN S JONES W LEWIS JL BARAKAT R CURTIN J ALMADRONES L HOSKINS W
Citation: M. Markman et al., THE USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TO PREVENT CARBOPLATIN-INDUCED ANEMIA, Gynecologic oncology, 49(2), 1993, pp. 172-176
SALVAGE INTRAPERITONEAL MITOXANTRONE THERAPY OF OVARIAN-CANCER - INFLUENCE OF INCREASING THE VOLUME OF TREATMENT
Authors: MARKMAN M HAKES T REICHMAN B RUBIN S CURTIN J BARAKAT R JONES W LEWIS JL ALMADRONES L HOSKINS W
Citation: M. Markman et al., SALVAGE INTRAPERITONEAL MITOXANTRONE THERAPY OF OVARIAN-CANCER - INFLUENCE OF INCREASING THE VOLUME OF TREATMENT, Gynecologic oncology, 49(2), 1993, pp. 185-189
IMPACT OF AGE ON SURVIVAL OF PATIENTS WITH OVARIAN-CANCER
Authors: MARKMAN M LEWIS JL SAIGO P HAKES T RUBIN S JONES W REICHMAN B CURTIN J BARAKAT R ALMADRONES L MORRISSEY T HOSKINS W
Citation: M. Markman et al., IMPACT OF AGE ON SURVIVAL OF PATIENTS WITH OVARIAN-CANCER, Gynecologic oncology, 49(2), 1993, pp. 236-239
RELATIONSHIP BETWEEN SALIVA AND SERUM CA-125 IN WOMEN WITH AND WITHOUT EPITHELIAL OVARIAN-CANCER
Authors: PLANTE M WONG GY NISSELBAUM JS ALMADRONES L HOSKINS WJ RUBIN SC
Citation: M. Plante et al., RELATIONSHIP BETWEEN SALIVA AND SERUM CA-125 IN WOMEN WITH AND WITHOUT EPITHELIAL OVARIAN-CANCER, Obstetrics and gynecology, 81(6), 1993, pp. 989-992
Risultati: 1-13 |